Furosemide-d5

CAT:
804-HY-B0135S
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Furosemide-d5 - image 1

Furosemide-d5

  • Description :

    Furosemide-d5 is the deuterium labeled Furosemide. Furosemide is a potent and orally active inhibitor of Na+/K+/2Cl-? (NKCC) cotransporter, NKCC1 and NKCC2[1].?Furosemide is also a GABAA?receptors antagonist and displays 100-fold selectivity for?α6-containing receptors than?α1-containing receptors. Furosemide acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema[2].
  • CAS Number :

    [1189482-35-6]
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    GABA Receptor; NKCC
  • Type :

    Isotope-Labeled Compounds
  • Related Pathways :

    Membrane Transporter/Ion Channel; Neuronal Signaling
  • Field of Research :

    Metabolic Disease; Cancer
  • Purity :

    99.85
  • Solubility :

    10 mM in DMSO|DMSO : ≥ 100mg/mL
  • Smiles :

    OC(C1=C(C=C(C(S(N)(=O)=O)=C1)Cl)NC([2H])([2H])C2=C([2H])C([2H])=C([2H])O2)=O
  • Molecular Formula :

    C12H6D5ClN2O5S
  • Molecular Weight :

    335.77
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]C M Gillen, et al. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J Biol Chem. 1996 Jul 5;271 (27) :16237-44.|[3]S A Thompson, et al. Residues in transmembrane domains I and II determine gamma-aminobutyric acid type AA receptor subtype-selective antagonism by Furosemide sodium. Mol Pharmacol. 1999 Jun;55 (6) :993-9.|[4] Shin Hye Kim, et al. Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide sodium-Treated Mice. Front Cell Neurosci. 2018 Jan 19;12:3.|[5]Atsushi Shiozaki , et al. Furosemide sodium, a blocker of Na+/K+/2Cl- cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0/G1 state. J Physiol Sci. 2006 Dec;56 (6) :401-6.|[6]Yuliya V Kucherenko, et al.Inhibitory effect of Furosemide sodium on non-selective voltage-independent cation channels in human erythrocytes.Cell Physiol Biochem. 2012;30 (4) :863-75.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide